Takashima S. §, Martin M. L. §, Jansen S.A. §, Fu Y, Bos J, Chandra D, O’Connor MH, Mertelsmann AM, Vinci P, Kuttiyara J, Devlin SM, Middendorp S,  Calafiore M, Egorova A,  Kleppe M, Lo Y, Shroyer NF, Cheng EH, Levine RL, Liu C, Kolesnick R, Lindemans CA* and Hanash AM*  T-cell-derived Interferon-γ programs stem cell death  in immune-mediated intestinal damage. Science Immunology 2019, Dec 6, 2019 *With In Focis  by Hans Clevers in same issue

 Ustun C, Kim S, Chen M, Beitinjaneh AM, Brown VI, Dahi PB, Daly A, Diaz MA, Freytes CO, Ganguly S, Hashmi S, Hildebrandt GC, Lazarus HM, Nishihori T, Olsson RF, Page KM, Papanicolaou G, Saad A, Seo S, William BM, Wingard JR, Wirk B, Yared JA, Perales MA, Auletta JJ, Komanduri KV, Lindemans CA, Riches ML. Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1, Blood Adv. 2019 Sep 10;3(17):2525-2536

Smits BM, Lelieveld PHC, Ververs FA, Turkenburg M, de Koning C, van Dijk M, Leavis HL, Boelens JJ, Lindemans CA, Bloem AC, van de Corput L, van Montfrans J, Nierkens S, van Gijn ME, Geerke DP, Waterham HR, Koenderman L, Boes M. A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease. Clin Immunol. 2019 Aug 2:108248.

 Szanto CL, Langenhorst J, de Koning C, Nierkens S, Bierings M, Huitema ADR, Lindemans CA*, Boelens JJ*. Predictors for Autoimmune Cytopenias after Allogeneic Hematopoietic Cell Transplantation in Children. Biol Blood Marrow Transplant. 2019 Jul 22.. doi: 10.1016/j.bbmt.2019.07.022.

Langenhorst J, van Kesteren C, van Maarseveen EM, Dorlo TP, Nierkens S, Lindemans CA De Witte MA, Bierings MB, Kuball J, Huitema ADR, Boelens  JJ. Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes, Blood advances, Accepted for publication, 2019 Jul 23;3(14):2179-218

van Dijk SJ, Domenighetti AA, Gomez-Ospina N., Hunter P, Lindemans CA, Veerle M, van Rossum AMC, Norman D. Rosenblum. Building a Professional Identity and an Academic Career Track in Translational Medicine. Frontiers in Medicine (Lausanne), section Translational Medicine, 2019 Jul 3;6:151. doi: 10.3389/fmed.2019.00151.

Abidi MZ, Hari P, Chen M, Kim S, Battiwala M, Dahi PB, Diaz MA, Gale RP, Ganguly S, Gergis U, Green J, Hildebrandt G, Hill JA, Komanduri K, Lazarus H, Marks D, Nishihori T, Olsson R, Seo S, Ustun C, Yared J, Yin D, Wingard J, Wirk BM, Auletta J, Lindemans C, Riches M. Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient  outcomes: a CIBMTR contemporary longitudinal study. Bone Marrow Transplant. 2019 Aug;54(8):1354-1360, (Impact factor 3.8)

 Nederlof I, Lindemans CA, Bierings MB, Mohseny AB, Bresters D, Bartels M. Recognizing a Non-classical Telomeropathy before Hematopoietic Stem Cell Transplantation in Pediatric Patients: A Case Series, Hemaspere  2019, Aug 1

Papanicolaou GA, Ustun C, Young J.H, Chen M, Kim S, Ahn KW, Komanduri K, Lindemans CA, Auletta JJ, and Riches ML, On behalf of the CIBMTR® Infection and Immune Reconstitution Working Committee. Bloodstream infection (BSI) due to Vancomycin-resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome. A multicenter retrospective cohort study. CID Jan  2019, doi: 10.1093/cid/ciz031 (Impact Factor 9.1)

Ferrua F, Galimbertid S, Courteillee V, Slatter M, Booth C, Moshousi D, Neven B, Laberkoj A, Shcherbinaj A, Balashovj D, MD, Soncinik E, Portak F, Al-Mousal H, ,Al-Saudl B, Al-Dhekril H, Arnaout R, Formankovam R, Bertrand Y, Langeo A, Smart J, Wolska-Kusnierz B, Aquinor V, Dvoraks C, Fastht A, Fouyssac F, Heilmann C, Hoenig M, Kelečićx J, Bredius R, Lankester A, Lindemans CA, Suarez F, Sullivan KE, Albert M, Kałwak K, Vincente B,, Bhatiaff M, Bordong V, Czogalahh W,  Diaz de Herediaii C, Dogujj F, Gozdzikkk J, …. Cowan MJ, Gennery A on behalf of SCETIDE, PIDTC, EBMT & ESID IEWP. Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC Study. J Allergy Clin Immunol. 2019 Jun;143(6):2238-2253 (Impact factor 12.5)

 Ustun C, Young JH, Papanicolaou GA, Kim S, Ahn KW, Chen M, Abdel-Azim H, Aljurf M, Beitinjaneh A, Brown V, Cerny J, Chhabra S, Kharfan-Dabaja MA, Dahi PB, Daly A, Dandoy CE, Dvorak CC, Freytes CO, Hashmi S, Lazarus H, Ljungman P, Nishihori T, Page K, Pingali SRK, Saad A, Savani BN, Weisdorf D, Williams K, Wirk B, Auletta JJ, Lindemans CA, Komanduri K, Riches M. Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2019 Aug;54(8):1254-1265 (Impact Factor 4.7)

Gostyńska KB, Yenamandra VK, Lindemans C, Duipmans J, Gostyński A, Jonkman MF,Boelens JJ. Allogeneic Haematopoietic Cell Transplantation for Epidermolysis Bullosa: the Dutch Experience. Acta Derm Venereol. 2019 Mar 1;99(3):347-348 (Impact Factor 3.1)

de Koning C, Langenhorst J, van Kesteren C, Lindemans CA, Huitema ADR, Nierkens S, Boelens JJ. Innate immune recovery predicts CD4+ T-cell reconstitution after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2018 Oct 22. . (Impact Factor 4.7)

Versluys B, Bierings M, Murk JL, Wolfs T, Lindemans C, Ent KV, Boelens JJ. Respiratory Virus prior to Hematopoietic Cell Transplantation is associated with  allo-immune mediated lung syndromes. J Allergy Clin Immunol. 2018 Feb;141(2):697-703 (Impact factor 12.5)

Leiding JW, Okada S, Hagin D, Abinun M, Shcherbina A, Balashov DN, Kim VHD, Ovadia A, Guthery SL, Pulsipher M, Lilic D, Devlin LA, Christie S, Depner M, Fuchs S, van Royen-Kerkhof A, Lindemans C, Petrovic A, Sullivan KE, Bunin N, Kilic SS, Arpaci F, Calle Martin O, Martinez-Martinez L, Aldave JC, Kobayashi M,  Ohkawa T, Imai K, Iguchi A, Roifman CM, Gennery AR, Slatter M, Ochs HD, Morio T,  Torgerson TR; Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the Primary Immune Deficiency Treatment Consortium. Hematopoietic stem cell transplantation in patients with gain-of-function signal  transducer and activator of transcription 1 mutations. J Allergy Clin Immunol. 2017 Jun 7. PMID: 28601685. (Impact factor 12.5)

Fischer JC, Bscheider M, Eisenkolb G, Lin CC, Wintges A, Otten V, Lindemans CA, Heidegger S, Rudelius M, Monette S, Porosnicu Rodriguez KA, Calafiore M, Liebermann S, Liu C, Lienenklaus S, Weiss S, Kalinke U, Ruland J, Peschel C, Shono Y, Docampo M, Velardi E, Jenq RR, Hanash AM, Dudakov JA, Haas T, van den Brink MRM, Poeck H. RIG I/MAVS and STING signaling promote gut integrity during irradiation- and immune mediated tissue injury. Sci Transl Med. 2017 Apr19;9(386). PubMed PMID:28424327. (Impact factor 16.7)

Admiraal R, de Koning CCH, Lindemans CA, Bierings MB, Wensing AMJ, Versluys AB, Wolfs TFW, Nierkens S, Boelens JJ. Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation. J Allergy Clin Immunol. 2017 Apr 7. (Impact factor 12.5)

Maziarz RT, Brazauskas R, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Lee JW, Liesveld JL, Ramanathan M, Reddy V, Savani BN, Smith FO, Strasfeld L, Taplitz RA, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML. Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study. Bone Marrow Transplant. 2017 Feb;52(2):270-278. (Impact factor 3.8)

Ballen K, Woo Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin MJ, Lazarus HM, MacMillan ML, Margolis DA, Marks DI, Norkin M, Rosenthal J, Saad A, Savani B, Schouten HC, Storek J, Szabolcs P, Ustun C, Verneris MR, Waller EK, Weisdorf DJ, Williams KM, Wingard JR, Wirk B, Wolfs T, Young JA, Auletta J, Komanduri KV, Lindemans C, Riches ML.   Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016, Sep;22(9):1636-45 (Impact Factor 4.7)

Admiraal R, Chiesa R, Lindemans CA, Nierkens S, Bierings MB, Versluijs AB, Hiwarkar P, Furtado Silva JM, Veys P, Boelens JJ. Leukemia-free survival in myeloid leukemia, but not in lymphoid leukemia, is predicted by early CD4+ reconstitution following unrelated cord blood transplantation in children: a multicenter retrospective cohort analysis. Bone Marrow Transplant. 2016 Oct;51(10):1376-1378. (Impact factor 3.8)

Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C, Fujiwara H, Byun J, Shono Y, Lindemans C, Calafiore M, Schmidt TC, Honda K, Young VB, Pennathur S, van den Brink M, Reddy P. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016 May;17(5):505-13 (Impact factor: 20)

Admiraal R, Lindemans CA, van Kesteren C, Bierings MB, Versluijs AB, Nierkens S, Boelens JJ. Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation. Blood. 2016 Dec 8;128(23):2734-2741(Impact factor: 13.2)

Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn KW, Chen M, Green J, Laughlin M, Lazarus HM, Marks D, Saad A, Seftel M, Saber W, Savani B, Waller E, Wingard J, Auletta JJ, Lindemans CA, Boeckh M, Riches ML. Impact of early CMV reactivation in cord blood stem cell recipients in the current era. Bone Marrow Transplant. 2016 Apr 4. (Impact factor 3.8)

Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016 May 19;127(20):2427-38. (Impact factor: 13.2)

H.P.J. van der Doef, E. Bathoorn, M.P.M. van der Linden, T.W.F. Wolfs, A.L.C. Minderhoud, M.B. Bierings, A.M. Wensing, C.A. Lindemans. Astrovirus outbreak at a pediatric hematology and hematopoietic stem cell transplant unit despite strict hygiene rules. Bone Marrow Transplant 2015, 2016 May;51(5):747-50 (Impact factor 3.8)

K.M. Williams, K.W. Ahn, M. Chen, M.D. Aljurf, A.L. Agwu, A.R. Chen, T.J. Walsh, P. Szabolcs, M.J. Boeckh, J.J. Auletta, C.A. Lindemans , J Zanis-Neto, M. Malvezzi, J. Lister, J.S. de Toledo Codina, K. Sackey,  J.L. Chakrabarty, P. Ljungman, J.R. Wingard, M.D. Seftel,S. Seo, G.A.Hale, B. Wirk, M.S. Smith, B.N. Savani, H.M. Lazarus, D.I. Marks, C. Ustun,H. Abdel-Azim, C.C. Dvorak, J. Szer, J. Storek , A. Yong, M.R. Riches. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic celltransplantation: a CIBMTR analysis. Bone Marrow Transplant. 2016 Jan 4.(Impact factor 3.8)

C.A. Lindemans*,  M. Calafiore*, A.M. Mertelsmann*, M.H. O’ Connor* , J.A. Dudakov, R.R. Jenq,  E. Velardi, L.F. Young, O.M. Smith, G. Lawrence, J.A. Ivanov , N. Luo, Ya-Yuan Fu, G. Hua, M.L. Martin, K.P. O’Rourke, Y-H Lo, M. Mokry, M. Romera-Hernandez,  T. Cupedo, L. Dow, E. E. Nieuwenhuis, N. F. Shroyer,  C. Liu , R. Kolesnick , M.R. van den Brink*, A.M. Hanash*  Interleukin-22 promotes intestinal stem cell-mediated epithelial regeneration, Nature 2015 Dec 24;528(7583):560-4. (Impact factor: 41)

C.A. Lindemans*,  L.C.J.  te Boome*, R. Admiraal , C.M. Jol-van der Zijde,  A.M. Wensing, A.B. Versluijs, M.B. Bierings, J. Kuball, J.J. Boelens Sufficient immunosuppression with Thymoglobulin is essential for a successful Haplo-myeloid Bridge in Haplo-Cord Blood Transplantation.  Biol Blood Marrow Transplant. 2015, (10):1839-45 (Impact Factor 4.7)

L.C. Te Boome*, C. Mansilla *, L.E. van der Wagen*, C.A. Lindemans, E.J. Petersen, E. Spierings,  K.A.Thus, K. Westinga, M. Plantinga, M.B. Bierings,  A.E. Broers, M.L. Cuijpers, G.W.van Imhoff, J.J. Janssen, C. Huisman, S. Zeerleder, G.Huls, J.J. Boelens,N.M. Wulffraat, J.C. Slaper-Cortenbach, J. Kuball  Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells. Leukemia. 2015 Sep;29(9):1839-46,  (Impact factor: 11.7)

C.A. Lindemans, K. van Besien. Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cells. Cytotherapy. 2015 Jun;17(6):723-729 (Impact factor: 3.2)

J.M. van Montfrans , L. Schulz, B. Versluys , A.de Wildt , T.Wolfs , M.Bierings,C. Gerhardt , C.A. Lindemans,  A. Wensing , J.J. Boelens. Viral PCR Positivity in Stoolbefore Allogeneic Hematopoietic Cell Transplantation Is Strongly Associated withAcute Intestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2015;21(4):772-4.(Impact factor: 4.7)

C. Wehr, A.R. Gennery, C.A. Lindemans, A. Schulz, M.  Hoenig, R. Marks, M.  Recher, B. Gruhn,  H.I. Heijnen , D. Meyer; Grigoleit, H Einsele, U Baumann,  T. Witte,  KW Sykora, S. Goldacker, L. Regairaz ,  S. Aksoylar  et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency, J Allergy Clin Immunol.  2015 Apr;135(4):988-97(Impact factor: 12.5)

 C.A. Lindemans  and A.M. Hanash The importance of bone marrow involvement in GVHD. Blood (2014);124 (6), 837-8(Impact factor: 13.2)

I.H. Bartelink, E.M. van Reij, C.E. Gerhardt, E.M.  van Maarseveen, A. de Wildt, A.B. Versluys, C.A. Lindemans, M.B. Bierings, J.J. Boelens. Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric HCT: maintaining efficacy with less toxicity. Biol Blood Marrow Transplant. (2013);20(3): 345-53 (Impact factor:4.7 )

C.A. Lindemans, R. Chiesa, P.J.  Amrolia, K. Rao,  O. Nikolajeva, A. de Wildt, C.E. Gerhardt,  K.C. Gilmour, M. Bierings, P. Veys , J.J. Boelens. The impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune-reconstitution and clinical outcome. Blood. 2013; 123 (1):126-32 (Impact factor: 13.2)

J.A. Hol, T.F. Wolfs, M.B. Bierings, C.A. Lindemans ,  A.B. Versluys, A. de Wildt,  C.E. Gerhardt, J.J. Boelens. Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients. Bone Marrow Transplant. (2013);49 (1): 95-101(Impact factor:3.8 )

W. Scheper, S. van Dorp, S. Kersting, F. Pietersma, C.A. Lindemans, S. Hol, .S Heijhuurs, Z. Sebestyen, C. Gründer , V. Marcu-Malin, A. Marchant, C. Donner, B. Plachter, D. Vermijlen , D. van Baarle, J. Kuball. γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia. (2013) Jan 1 (Impact factor: 11.7)

T. Daikeler, M. Labopin, A. Ruggeri, A. Crotta, M. Abinun, A. Hussein, K. Carlson, J. Cornillon, J.L. Díez-Martín, G. Virginie, M. Faraci, C. Lindemans, A. O`Meara, M. Renard, P Sedlacek, A. Sirvent, G. Socie, F. Sora, S. Varotto, J. Sanz, J. Voswinkel, A. Vora, A. Yesilipek, A. Herr, E. Gluckman, D. Farge, and V. Rocha New Autoimmune Diseases after Cord Blood Transplantation -A Retrospective Study of EUROCORD and the Autoimmune Disease Working Party of EBMT. Blood ( 2013) ;121(6):1059-64 (Impact factor: 13.2)

M.E. van Egmond, P.J.W. Pauwels, J.J. Boelens, C.A. Lindemans, F. Barkhof, M.D. Steenwijk, P.M. van Hasselt, M.S. van der Knaap, N. I. Wolf Improvement of brain MRI after stem cell transplantation in metachromatic leukodystrophy, (2013) Archives of Neurology. 2013 Jun;70(6):779-82. (Impact factor: 5.7)

C.A. Lindemans *, J.F. Swart *, A. van Royen, J.J. Boelens, B.J. Prakken and N.M. Wulffraat Changing winds in refractory autoimmune disease in Children: clearing the road for tolerance with cellular therapies. (2012) Curr Opin Rheumatol. (2012);24(3):267-73. (Impact factor: 4.3)

C. A. Lindemans, A. M. Leen, J. J. Boelens How I treat Adenovirus infections (2010) Blood 116:5476-85.(Impact factor: 13.2)

C. A. Lindemans, J.L.L. Kimpen, L.J. Bont. The role of toll pathways in viral respiratory disease during early childhood, (2009) Current Molecular Medicine (Impact factor: 4.5)

C. A. Lindemans, P.J. Coffer, I.S. Schellens, P. M. A. de Graaff , J.L.L. Kimpen and L. Koenderman. Respiratory Syncytial Virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-Kinase and NFKB-dependent mechanism. (2006) J lmmunol;176:5529-37 . (Impact factor: 5.8)

C.A. Lindemans*, B. Luijk*, J. Heidema, D. Kanters, C. K. van der Ent and L. Koenderman Systemic Eosinophil Response induced by Respiratory Syncytial Virus. (2006) Clin Exp lmmunol.;144:409-17. (Impact factor: 3.4)

M. Rosas, P.F. Dijkers, C.A. Lindemans, L. Koenderman, P. J Coffer IL-5-mediated eosinophil survival requires inhibition of GSK-3 and correlates with beta-catenin relocalization. (2006) J Leukoc Biol.;80:186-95 (Impact factor: 5.0)

C. A. Lindemans, J.L.L. Kimpen The immune response to viral lower respiratory tract infection (2005), Adv. Exp Med Biol. ;568:41-65.(Impact factor:1.1)

B. Luijk, C. Lindemans, D. Kanters,R. van der Heijde, P. Bertics, J.W Lammers, M.E Bates and L Koenderman Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge; (2005) J Allergy Clin lmmunol.; 115:997-1003(Impact factor: 11)

C.A. Lindemans, P.J. Coffer Regulation of granulocyte apoptosis by phosphatidyl-inositol 3-kinase. (2004) Biochem Soc Trans. ;32:480-4. Review.(Impact factor: 3.7)

F. Groenendaal, C.A. Lindemans, C. Uiterwaal, L.S. de Vries. Early arterial Lactate and Prediction of outcome in preterm neonates admitted to a neonatal intensive care unit. (2003) Biol. Neonate.; 83(3):171-6. (Impact factor: 2.7)

C.A. Lindemans, R.A. Bruinsma, F.H. L. Broker, H.G.M. Arets, Consolidation of a pulmonary lobe with increased infection parameters: an unexpected mass, (2009) Monaldi Arch. of Chest Dis 71 ;71-5